MAP4 (drug)
MAP4 (Drug)[edit | edit source]
MAP4 is a synthetic compound that has been studied for its potential therapeutic effects in various medical conditions. It is classified as a psychoactive drug and has been the subject of research due to its unique pharmacological properties.
Chemical Structure and Properties[edit | edit source]
MAP4, chemically known as 1-(4-methoxyphenyl)-2-(methylamino)propan-1-one, belongs to the class of cathinones, which are structurally related to amphetamines. The compound is characterized by the presence of a methoxy group attached to the phenyl ring, which is believed to influence its pharmacological activity.
Pharmacology[edit | edit source]
MAP4 acts primarily as a monoamine releasing agent, with a particular affinity for the release of serotonin, dopamine, and norepinephrine. This mechanism of action is similar to that of other stimulant drugs, which can lead to increased alertness, energy, and euphoria. However, the exact receptor binding profile and the long-term effects of MAP4 are still under investigation.
Therapeutic Potential[edit | edit source]
Research into MAP4 has explored its potential use in treating conditions such as depression, attention deficit hyperactivity disorder (ADHD), and narcolepsy. Its ability to modulate neurotransmitter levels suggests it could be beneficial in these disorders, although clinical trials are necessary to establish its efficacy and safety.
Side Effects and Risks[edit | edit source]
As with many psychoactive substances, MAP4 may have side effects, including increased heart rate, hypertension, anxiety, and insomnia. There is also a potential for abuse and dependence, which necessitates careful consideration in any therapeutic application.
Legal Status[edit | edit source]
The legal status of MAP4 varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of approved medical use. Researchers must comply with regulatory requirements when studying MAP4.
Also see[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
This psychoactive drug related article is a stub.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
